According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,96ย โฌ. In 2018 the company made an earnings per share (EPS) of -335,24ย โฌ an increase over its 2017 EPS that were of -428,18ย โฌ.